Skip to main content
iMIS
Sign in
Cart
Toggle navigation
Sign in
Cart
This item is inactive
SGLT2 Inhibitors and Cardiovascular Outcomes
The focus of this program is on atherosclerotic cardiovascular disease, heart failure, and SGLT2 inhibitors and provides timely insights into implementing evidence-based treatment strategies. Darren McGuire, MD, MHSc summarizes the glycemic and non-glycemic effects of SGLT2 Inhibitors, their safety profile and recent clinical outcome trials. Cindy Lamendola MSN, ANP-BC, presents case studies that highlight the role of SGLT2 inhibitors in a non-diabetic patient with ASCVD and HF.
Your price:
0.00
Must be between 0 and 1000000.
Quantity:
Quantity is required.
Quantity must be a positive whole number.
Similar products
Leadership Series: Diversity, Equity, Inclusion
Advancing Patient Centered Care - Shared Decision ...
Cardio-Oncology: Preventing/ Treating...
Cardiac Diagnostics
Exercise and Lifestyle Interventions
The QT Interval: Too Hot, Too Cold, Just Right
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##